4-Antibody and Human Genome will use 4-Antibody's Retrocyte Display technology to discover and develop human antibodies against two targets selected by HGSI

4-Antibody AG

Switzerland / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Human Genome Sciences Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

$2,990.2m on 08/12/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced